Skip to main content
. 2018 Feb 2;8:2290. doi: 10.1038/s41598-018-20434-w

Table 2.

Associations between leucocyte telomere length and stroke in the first case/control study of Southern Chinese population.

Variables Highest tertile (>2.06) Middle tertile (1.52–2.06) Lowest tertile (<1.52) P trend Per 1-S.D. decrease in Ln-transformed telomere length P
Controls (n = 616) 206 205 205
Total cases (n = 543) 179 147 217
ORs (95% CI)
 No adjustment 1.0 0.83 (0.62–1.11) 1.22 (0.92–1.61) 0.03 1.11 (1.00–1.22) 0.048
 Model I 1.0 0.79 (0.55–1.13) 1.04 (0.74–1.47) 0.23 1.07 (0.95–1.21) 0.27
 Model II 1.0 0.82 (0.56–1.20) 1.05 (0.72–1.51) 0.38 1.07 (0.94–1.22) 0.33
Hemorrhagic stroke (n = 94) 33 21 40
ORs (95% CI)
 No adjustment 1.0 0.64 (0.36–1.14) 1.22 (0.74–2.01) 0.08 1.16 (0.96–1.42) 0.13
 Model I 1.0 0.82 (0.34–1.97) 0.91 (0.40–2.07) 0.91 1.08 (0.80–1.46) 0.61
 Model II 1.0 0.73 (0.27–1.97) 0.89 (0.36–2.20) 0.82 1.05 (0.75–1.46) 0.78
Atherothrombotic stroke (n = 224) 51 67 106
ORs (95% CI)
 No adjustment 1.0 1.32 (0.87–1.99) 2.09 (1.42–3.07) 0.001 1.39 (1.21–1.60) <0.001
 Model I 1.0 1.47 (0.90–2.40) 2.39 (1.50–3.80) 0.001 1.49 (1.26–1.75) <0.001
 Model II 1.0 1.43 (0.84–2.41) 2.33 (1.42–3.83) 0.003 1.48 (1.24–1.76) <0.001
Lacunar infarction (n = 225) 95 59 71
ORs (95% CI)
 No adjustment 1.0 0.62 (0.43–0.91) 0.75 (0.52–1.08) 0.04 0.87 (0.75–1.00) 0.053
 Model I 1.0 0.50 (0.31–0.79) 0.51 (0.32–0.80) 0.003 0.74 (0.61–0.88) 0.001
 Model II 1.0 0.52 (0.31–0.85) 0.49 (0.30–0.81) 0.007 0.72 (0.59–0.88) 0.001

The cut-off values of tertile of leucocyte telomere length (relative T/S ratio) were derived from the control group, with <1.52 for the lowest, 1.52–2.06 for the middle and >2.06 for the highest tertile (as the reference). OR (95% CI) was obtained with multivariate logistic regression analysis.

Model I: adjustment for age, gender, systolic and diastolic BP, fasting glucose, total cholesterol, triglycerides, plasma uric acid, and body mass index.

Model II: adjustment for the covariates mentioned above plus smoking status, alcohol intake, history of hypertension, diabetes, and previous CHD.